BioSpace News Archive

Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, announced that it will present virtually at the 11th Annual SVB Leerink Healthcare Conference being held Feb. 14-18, 2022.

Bruker CorporationBruker CorporationBruker Corporation announced financial results for its fourth quarter and for the fiscal year ended December 31, 2021.

M6P Therapeutics (“M6PT” or “the Company”), a privately held life sciences company developing next-generation enzyme replacement and gene therapies for lysosomal storage disorders (LSDs), today announced the presentation of promising preclinical data at the 18th Annual WORLDSymposium™.

Vor Biopharma, a clinical-stage cell and genome engineering company, announced that Dr. Robert Ang, Vor’s President and Chief Executive Officer, will present virtually at the 11th Annual SVB Leerink Global Healthcare Conference.

IVERIC bio, Inc. (Nasdaq: ISEE) announced today a post-hoc analysis which evaluated various Geographic Atrophy (GA) growth parameters to explore the rate of disease progression within various regions in the fovea in a subset of patients from the GATHER1 Zimura® (avacincaptad pegol) Phase 3 clinical trial for the treatment of GA.

Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced its intention to present data at two medical meetings.

Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the second quarter of fiscal year 2022, which ended December 31, 2021.

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced 12-month data from the SENZA-NSRBP randomized controlled trial (RCT) was published online in Journal of Neurosurgery: Spine.

Adial Pharmaceuticals, Inc. announced that it has entered into a securities purchase agreement with a single institutional investor to purchase approximately $10 million of its common stock in a registered direct offering and warrants to purchase common stock in a concurrent private placement.

A nicotine patch is a device that delivers nicotine into the body through the skin. This patch is usually used to help prevent nicotine cravings that smokers experience when trying to quit smoking.